March 20th - Dr. Emily Liang- Development and validation of predictive models of early immune effector cell–associated hematotoxicity

CME Congresses .

March 20th Dr. Emily Liang- Development and validation of predictive models of early immune effector cell–associated hematotoxicity

March 4th- Dr. Eli Muchtar- Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

CME Congresses .

March 4th – Dr. Eli Muchtar- Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

Feb 19th - Prof. Maria Teresa Voso- Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

CME Congresses .

Feb 19th – Prof. Maria Teresa Voso- Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

Feb 9th - Prof. Rahul Banerjee- Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

CME Congresses .

Feb 9th – Prof. Rahul Banerjee- Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

Feb 3rd- Prof. Ahraf Badros- Daratumumab with Lenalidomide as Maintenance After Transplant in Newly Diagnosed Multiple Myeloma: the AURIGA Study

CME Congresses .

Feb 3rd- Prof. Ahraf Badros- Daratumumab with Lenalidomide as Maintenance After Transplant in Newly Diagnosed Multiple Myeloma: the AURIGA Study

January 19th 2025- Dr. Rohtesh Mehta- Haploidentical vs HLA-Matched Sibling Donor HCT with PTCy Prophylaxis: HLA Factors and Donor Age Considerations

CME Congresses .

January 19th 2025- Dr. Rohtesh Mehta- Haploidentical vs HLA-Matched Sibling Donor HCT with PTCy Prophylaxis: HLA Factors and Donor Age Considerations

January 15th 2025- Dr. William Wesson- Optimizing the Post-CAR T Monitoring Period in Recipients of Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel

CME Congresses .

January 15th 2025- Dr. William Wesson- Optimizing the Post-CAR T Monitoring Period in Recipients of Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel

January 5th 2025- Dr. Irina Amitai- Germ Line ERG Haploinsufficiency Defines a New Syndrome with Cytopenia and Hematological Malignancy Predisposition

CME Congresses .

Dr. Irina Amitai- Germ Line ERG Haploinsufficiency Defines a New Syndrome with Cytopenia and Hematological Malignancy Predisposition

December 31st 2024- Dr. Eduardo Rego- Clinical Networking Results in Continuous Improvement of the Outcome of Patients with Acute Promyelocytic Leukemia

CME Congresses .

Dr. Eduardo Rego- Clinical Networking Results in Continuous Improvement of the Outcome of Patients with Acute Promyelocytic Leukemia

December 23rd 2024- Dr. Omran Saifi- Outcomes of Patients with R/R B-Cell NHL and Limited (<5 sites) pre-CAR T Disease Bridged With or Without Radiotherapy

CME Congresses .

Dr. Omran Saifi- Outcomes of Patients with R/R B-Cell NHL and Limited (<5 sites) pre-CAR T Disease Bridged With or Without Radiotherapy